DK0833903T3 - Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus - Google Patents

Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus

Info

Publication number: DK0833903T3
Authority: DK; Denmark
Prior art keywords: bovine coronavirus; bcv; cattle; multivalent; vaccine
Prior art date: 1995-06-12

Application number

DK96923275T

Other languages

Danish (da)

English (en)

Inventor

Sanjay Kapil

Original Assignee

Univ Kansas State

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-12

Filing date

1996-06-07

Publication date

2005-01-03

1996-06-07 Application filed by Univ Kansas State filed Critical Univ Kansas State

2005-01-03 Application granted granted Critical

2005-01-03 Publication of DK0833903T3 publication Critical patent/DK0833903T3/da

Links

241000711443 Bovine coronavirus Species 0.000 title abstract 7
229960005486 vaccine Drugs 0.000 title abstract 3
208000001528 Coronaviridae Infections Diseases 0.000 title abstract 2
241000283690 Bos taurus Species 0.000 abstract 3
241000700605 Viruses Species 0.000 abstract 2
208000017667 Chronic Disease Diseases 0.000 abstract 1
GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 abstract 1
210000003608 fece Anatomy 0.000 abstract 1
GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 abstract 1
229940097277 hygromycin b Drugs 0.000 abstract 1
230000036039 immunity Effects 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Mycology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK96923275T 1995-06-12 1996-06-07 Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus DK0833903T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48961495A	1995-06-12	1995-06-12
EP19960923275 EP0833903B1 (fr)	1995-06-12	1996-06-07	Nouveau vaccin multivalent a base de virus corona bovin et methode de traitement de l'infection au virus corona bovin

Publications (1)

Publication Number	Publication Date
DK0833903T3 true DK0833903T3 (da)	2005-01-03

Family

ID=23944554

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96923275T DK0833903T3 (da)	1995-06-12	1996-06-07	Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus

Country Status (10)

Country	Link
US (1)	US5916570A (fr)
EP (1)	EP0833903B1 (fr)
AT (1)	ATE274579T1 (fr)
AU (1)	AU705186B2 (fr)
CA (1)	CA2224309C (fr)
DE (1)	DE69633233T2 (fr)
DK (1)	DK0833903T3 (fr)
ES (1)	ES2224172T3 (fr)
PT (1)	PT833903E (fr)
WO (1)	WO1996041874A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU725439B2 (en) *	1997-03-10	2000-10-12	Bayer Corporation	Bovine respiratory coronavirus as a vaccine
AU2001264802A1 (en)	2000-05-21	2001-12-03	University Of North Carolina At Chapel Hill	Assembly of large viral genomes and chromosomes from subclones
US6974577B2 (en) *	2001-02-04	2005-12-13	Novartris Ag	Inactivated bovine scours vaccines, processes and method of preventing bovine scours
US7906311B2 (en) *	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
GB0217434D0 (en) *	2002-07-27	2002-09-04	Royal Vetinary College	Biological material
US9023366B2 (en)	2003-07-01	2015-05-05	The Royal Veterinary College	Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) *	2003-07-01	2003-08-06	Royal Veterinary College	Vaccine composition
AU2010273382A1 (en) *	2009-07-17	2012-02-02	The Board Of Regents For Oklahoma State University	Supralingual vaccines and applicators
CA2699024C (fr)	2009-11-06	2016-12-13	Intervet International B.V.	Methodes d'immunisation des genisses adolescentes pleines a trois mois de gestation
KR102243374B1 (ko) *	2019-09-30	2021-04-22	대한민국	소 코로나바이러스, 소 로타바이러스 및 소 바이러스성설사병바이러스에 대한 백신 조성물
KR102234525B1 (ko) *	2020-08-28	2021-03-30	안병철	송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3839556A (en) *	1969-11-28	1974-10-01	Univ Nebraska	Calf diarrhea virus vaccine and processes
US3838004A (en) *	1970-11-17	1974-09-24	Univ Nebraska	Calf diarrhea virus vaccine and processes
US3869547A (en) *	1971-11-10	1975-03-04	Univ Nebraska	Calf diarrhea virus vaccine and processes
US3914408A (en) *	1973-10-12	1975-10-21	Univ Nebraska	Vaccine for neonatal calf diarrhea

1996
- 1996-06-07 PT PT96923275T patent/PT833903E/pt unknown
- 1996-06-07 ES ES96923275T patent/ES2224172T3/es not_active Expired - Lifetime
- 1996-06-07 AT AT96923275T patent/ATE274579T1/de active
- 1996-06-07 DK DK96923275T patent/DK0833903T3/da active
- 1996-06-07 DE DE1996633233 patent/DE69633233T2/de not_active Expired - Lifetime
- 1996-06-07 EP EP19960923275 patent/EP0833903B1/fr not_active Expired - Lifetime
- 1996-06-07 CA CA 2224309 patent/CA2224309C/fr not_active Expired - Lifetime
- 1996-06-07 AU AU63832/96A patent/AU705186B2/en not_active Ceased
- 1996-06-07 WO PCT/US1996/009979 patent/WO1996041874A1/fr not_active Ceased
1997
- 1997-02-04 US US08/795,294 patent/US5916570A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0833903B1 (fr)	2004-08-25
EP0833903A1 (fr)	1998-04-08
US5916570A (en)	1999-06-29
CA2224309C (fr)	2011-01-25
WO1996041874A1 (fr)	1996-12-27
ATE274579T1 (de)	2004-09-15
EP0833903A4 (fr)	1999-03-24
DE69633233T2 (de)	2005-08-11
AU705186B2 (en)	1999-05-20
ES2224172T3 (es)	2005-03-01
CA2224309A1 (fr)	1996-12-27
PT833903E (pt)	2004-11-30
AU6383296A (en)	1997-01-09
DE69633233D1 (de)	2004-09-30

Similar Documents

Publication	Publication Date	Title
ES2176232T3 (es)	2002-12-01	Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
YU92102A (sh)	2006-01-16	Metode i smeše za lečenje virusnog hepatitisa c
PT815235E (pt)	2003-06-30	Vacinas para peste
ATE271063T1 (de)	2004-07-15	Purin-l-nukleoside, deren analoga und verwendungen
UA66744C2 (en)	2004-06-15	5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DK0833903T3 (da)	2005-01-03	Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus
FR2814958B1 (fr)	2003-03-07	Composition vaccinale
LU91595I2 (fr)	2009-10-12	Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
LU90203I2 (fr)	1998-04-06	Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables
BG98522A (bg)	1995-05-31	Пептиди, индуциращи цитотоксичен т-лимфоцитен отговор на вируса на хепатит в
ATE226829T1 (de)	2002-11-15	Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten
ATE416788T1 (de)	2008-12-15	Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
DK0563254T3 (da)	1996-02-12	Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
LU90378I2 (fr)	1999-05-31	Tetravac
EP0090660A3 (fr)	1983-11-23	Vaccin anti-gonococcique
HUP9700975A2 (hu)	1998-05-28	Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
AR010568A1 (es)	2000-06-28	Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
ES2162862T3 (es)	2002-01-16	Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ATE84722T1 (de)	1993-02-15	Tollwut-lebendimpfstoff.
EP1143981A4 (fr)	2003-08-13	Traitement et prevention d'infections par le vih et d'autres infections virales
FR2792639B1 (fr)	2003-06-06	Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
RU94032103A (ru)	1995-09-27	Пептиды, фармацевтическая композиция, вакцина, конъюгат, способы лечения и идентификации
HUT54505A (en)	1991-03-28	Process for producing subunit vaccine against avjeszky disease of swine
CO4750675A1 (es)	1999-03-31	Vacuna de env-glucoproteina para la proteccion contra la infeccion con vlcth-i y vclth-ii